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        Eff  orts to generate a vaccine against HIV 
have been disappointing, perhaps be-
cause of the unique tropism of HIV for 
CD4 
+  T cells. Infection with HIV is as-
sociated with rapidly acquired defects 
in cell cycle initiation in CD4 
+  cells and 
cytoxicity in CD8 
+  T cells (  1  ). Ulti-
mately T cells become dysfunctional and 
fail to generate immune responses, leav-
ing the patient vulnerable to opportunis-
tic infections. The rapid onset of T cell 
dysfunction in HIV-infected patients in-
variably hinders early attempts to boost 
the immune system using vaccines and 
other interventions. Exhaustion of CD4 
+  
and CD8 
+  T cells during HIV and other 
chronic viral infections has been associ-
ated with sustained expression of the in-
hibitory molecule PD-1, which results 
in inhibition of T cell expansion and cy-
tokine production (  2  –  4  ). However, as 
not all exhausted cells express PD-1, it 
is likely that other molecules may con-
tribute to the exhaustion associated with 
HIV infection and other chronic viral in-
fections. On p.   2763   of this issue, Jones 
et al. identify a novel molecular mecha-
nism for T cell exhaustion mediated by 
the expression of TIM-3 (  5  ). 
  The in  TIM  idation of T cells 
  The TIM family of genes, which con-
sists of eight members in mice and three 
members in humans (  6  ), is located on 
chromosome 11 in mice and 5q33 in 
humans  —  genetic regions that have been 
associated with autoimmune and allergic 
diseases. TIM proteins are type 1 mem-
brane proteins with a structurally con-
served immunoglobulin variable (IgV) 
domain and mucin stalk that connects to 
an intracellular tail. TIM proteins were 
initially thought to be expressed specifi  -
cally on the surface of diff  erentiated ef-
fector T cells and to directly regulate 
their activity, but we now know that 
TIMs are also expressed on and regulate 
the function of antigen-presenting cells 
(  7  ). Crystal structures of the TIM mole-
cules has revealed a unique, conserved 
structure with ligand-binding sites in the 
IgV domain (  8  –  10  ). 
  TIM-3 was initially identifi  ed as a 
molecule expressed on T helper (Th)-1, 
but not Th2, cells in mice (  11  ). Interac-
tion between TIM-3 and its ligand ga-
lectin-9 inhibits Th1 responses (  12  ) and 
induces peripheral tolerance (  13, 14  ). 
As in mice, TIM-3 is preferentially ex-
pressed on human Th1 cells, but is also 
expressed constitutively on macrophages 
and dendritic cells (DCs) ( 7  ). Reduction 
of TIM-3 expression in T cells using 
small interfering RNA or blocking an-
tibodies, for example, increases in-
terferon (IFN)-     secretion by CD4 
+   T 
cells (  15  ), further supporting an inhibi-
tory role of TIM-3 in human T cells. 
Patient studies are consistent with this 
inhibitory function, as TIM-3 expres-
sion is defective on CD4 
+  T cells from 
patients with autoimmune diseases (  15, 
16  ). Specifi  cally, T cell clones isolated 
from the cerebrospinal fl  uid of patients 
with multiple sclerosis (MS) express 
lower levels of TIM-3 and secrete higher 
levels of IFN     compared with clones 
isolated from healthy control subjects 
(  15  ). CD4 
+   T cells from MS patients 
also show altered and delayed kinetics 
of TIM-3 upon activation, resulting in 
lower TIM-3 expression on circulating 
T cells and are therefore refractory to 
the blocking eff  ects of TIM-3  –  specifi  c 
antibodies (  16  ). 
  TIM-1, by contrast, is predominantly 
expressed on Th2 cells and was fi  rst iden-
tifi  ed as the hepatitis A virus cellular 
receptor 1 (  17  ). A unique polymorphism 
in the mucin domain of TIM-1 regulates 
hepatitis A virus infection, and also af-
fects immune responses and resistance to 
asthma, allergy, and atopy (  18  ). 
  TIM-3 in chronic virus infection 
  T cell exhaustion during HIV infection 
is accompanied by increased HIV rep-
lication and follows a characteristic pat-
tern. T cells fi  rst lose the ability to enter 
into cell cycle, to secrete IL-2, and to 
mediate cytotoxicity (2, 3). Over time, 
the exhausted cells also lose the ability 
to secrete other cytokines, such as IFN-
 and TNF (2, 3, 19). Initial studies 
suggested that T cell dysfunction is me-
diated by sustained PD-1 expression 
on T cells. Upon activation, T cells up-
regulates several inhibitory molecules, 
including PD-1, which help turn off   
T cell responses and thus inhibit T cell 
expansion. 
  A functional role for PD-1/PD-L1 
signaling in T cell dysfunction was dem-
onstrated by studies of lymphocytic 
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protein-3 (TIM-3) in T cell exhaustion during chronic HIV infection and sug-
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suggesting that, like PD-1, TIM-3 may be 
an important marker of exhausted T cells 
during chronic viral infections. Blocking 
the interaction between TIM-3 and its 
ligand galectin-9 enhanced CD8 
+   T cell 
proliferation and cytokine production 
in response to HLA-A*0201-restricted 
HIV-1 peptides, thus solidifying the 
functional connection between TIM-3 
expression and T cell dysfunction (  Fig. 
1  ).   Inhibiting the TIM-3 pathway also 
enhanced CD4 
+   and CD8 
+   T cell prolif-
eration when peripheral blood mono-
nuclear cells from chronic progressors 
were stimulated with pooled Gag and 
Nef peptides. In most of the patients, 
TIM-3 and PD-1 were expressed on dis-
tinct populations of T cells, although in-
frequent TIM-3 
+  /PD-1 
+   cells could be 
detected. These data suggest that TIM-3 
and PD-1 expression mark distinct sub-
sets of exhausted T cells. The authors 
The frequency of TIM-3  –  expressing cells 
correlated positively with viral load and 
inversely with CD4 
+   T cell counts. These 
results are in sharp contrast to data show-
ing decreased expression of TIM-3 in 
  patients with MS. Staining with MHC 
class I tetramers/pentamers revealed higher 
TIM-3 expression on HIV-specifi  c CD8 
+   
T cells than on CMV-specifi  c CD8 
+   T 
cells. Levels of TIM-3 expression were 
variable both among diff  erent individuals 
and among HIV-specifi  c T cells within 
the same individual, suggesting that diff  er-
ent levels of TIM-3 expression may mark 
cells with diff  erent functional capacities. 
  In a subset of patients, highly active 
antiretroviral therapy correlated with 
  reduced TIM-3 expression on T cells. 
Sorting of TIM-3 
+   and TIM-3 
      popula-
tions revealed that HIV-specifi  c T cells 
expressing high amounts of TIM-3 se-
creted less IFN     than did TIM-3 
      cell, 
choriomeningitis virus in mice, simian 
immune defi  ciency syndrome in rhesus 
macaques, and HIV in humans, each of 
which demonstrated that blocking this 
pathway increased T cell responses, im-
proved viral control in vivo, and en-
hanced the survival and proliferation of 
antigen-specifi  c CD8
+ T cells in vitro 
(2, 3, 20, 21). Although PD-1 expression 
appeared to identify a population of T 
cells entering into exhaustion, not all ex-
hausted cells expressed PD-1 (3). Thus, 
the molecular pathways associated with T 
cell exhaustion, particularly in CD8
+ T 
cells, remain incompletely understood. 
  In this issue, Jones et al. fi  nd elevated 
expression of TIM-3 on both CD4 
+   
and CD8 
+   T cells from individuals with 
acute and progressive chronic HIV in-
fection, but not in chronically infected 
individuals who had controlled the in-
fection or in uninfected individuals (  5  ). 
    Figure 1.         Differential expression of TIM-3 on the surface of T cells regulates susceptibility to viral infection or development of autoim-
mune injury.   (A) In patients with progressive HIV infection, TIM-3 is up-regulated on the surface of CD4 and CD8 T cells. Up-regulation of TIM-3 on HIV-
specifi  c CD8 T cells leads to impaired cell survival, proliferation, and cytokine production (1). Blocking TIM-3 binding to its ligand galectin-9 using soluble 
TIM-3 or TIM-3 antibody restores functionality of HIV-specifi  c CD8 T cells from HIV patients. Up-regulation of PD-1 in HIV patients also leads to T cell 
dysfunction (2). Although a small proportion of cells express both TIM-3 and PD-1, in the majority of cells, TIM-3 expression is distinct from PD-1, sug-
gesting these proteins defi  ne separate populations of dysfunctional T cells in HIV patients. (B) In autoimmune diseases, autoreactive T cells upon activa-
tion and expansion down-regulate TIM-3 expression, leading to progressive uncontrolled growth and expansion of autoreactive T cells. Whether 
down-regulation of TIM-3 is mediated by genetic factors or by T cell activation signals in autoimmune disease is not known.     JEM VOL. 205, November 24, 2008  2701
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suggest that TIM-3 may be an impor-
tant therapeutic target that is distinct 
from PD-1 and may help reverse ex-
haustion in chronic viral infections. On 
CD4 
+   cells, TIM-3 is expressed only 
on terminally differentiated Th1 cells. 
Thus TIM-3 blockade would result in 
the expansion of only eff  ector T cells.   
Therapeutic blockade of PD-1, on the 
other hand, would expand all T cells, 
because PD-1 is up-regulated on all ac-
tivated T cells. 
  Open questions 
  Collectively, these data suggest that 
TIM-3 is a central regulator of T cell re-
sponses. In autoimmunity, loss of TIM-3 
function leads to excessive expansion of 
autoreactive eff  ector T cells. In chronic 
HIV infection, by contrast, sustained 
TIM-3 expression on CD4 
+   and CD8 
+   
T cells leads to T cell exhaustion (  Fig. 1  ). 
As with any clinical observation, these 
results raise many questions. It is un-
clear, for example, whether HIV infec-
tion itself drives TIM-3 expression or 
whether CD4 
+   T cells expressing high 
levels of TIM-3 are preferentially in-
fected with HIV or are exhausted in 
their attempt to clear the virus. How 
the engagement of TIM-3 by its ligand 
galectin-9 leads to the inability of T cells 
to enter into the cell cycle and secrete 
cytokines is also unknown. Since TIM-
3  –  galectin-9 interactions normally induce 
the death of terminally diff  erentiated Th1 
cells (  12  ), why aren  ’  t exhausted cells 
eliminated? And why, on the other hand, 
is TIM-3 expression reduced on Th1 cells 
in patients with autoimmune diseases 
such as MS? 
  Our recent discovery that TIM-3 is 
constitutively expressed by human DCs 
and monocytes revealed a potential role 
for TIM-3 in innate immune responses 
(  7  ). It will be interesting to examine the 
function of TIM-3 on monocytes and 
DCs in patients with HIV infection, 
whether its expression changes during 
the course of infection, and whether 
TIM-3 aff  ects the responsiveness of DCs 
to TLR and other innate signals. 
  The dysregulation of TIM-3 in pa-
tients with autoimmune disease and in 
chronic viral exhaustion highlight the 
therapeutic potential of targeting TIM-
3 in the treatment of these diseases. Fi-
nally, these studies highlight the utility 
of investigating the same regulatory 
pathways in patients with HIV and au-
toimmunity to provide unique insights 
into the pathogenesis of these diseases. 
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